37 State Attorneys General Urge FDA Action on Counterfeit Weight Loss Drugs

A bipartisan coalition of attorneys general from 37 states is urging the FDA to take decisive action against the rising threat of counterfeit weight loss and diabetes drugs, specifically GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound. These counterfeit drugs, often sourced from countries such as China and Turkey, pose significant health risks due to unregulated and potentially harmful ingredients being sold online without prescriptions. The attorneys general emphasize the need for the FDA to increase enforcement against illegal sellers and partner with state pharmacy boards to ensure the safety of compounded medications. This push comes as the demand for obesity drugs skyrockets, leading to supply shortages and creating opportunities for counterfeiters to exploit consumers. The coalition highlights the urgent need for consumer protection amidst these alarming trends in the drug market. They have called on the FDA to leverage its expertise and resources to combat these deceptive practices effectively.